Latest filing published 07 May 2024 for Precision Biosciences INC.
Insider track record
No signal scores available.
Samuel C. Wadsworth: trading record in brief
Samuel C. Wadsworth discloses dealings in 2 companies, chiefly Dimension Therapeutics, Inc. and Precision Biosciences Inc. We count 2 filings; the first trade dates from 7 November 2017 and the latest from 4 May 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 7 May 2024, reports an option exercise in Precision Biosciences Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Samuel C. Wadsworth
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,202 sharesCommon StockSEC:0000950170-24-054584:0
- 278,035 sharesCommon StockSEC:0001209191-17-059634:0
2 of 2 declarations